Results 161 to 170 of about 35,299 (221)

P68 ‐ Immunogenicity of 13‐valent conjugate pneumococcal vaccine (PCV13) in children with asthma or recurrent wheeze receiving inhaled corticosteroids (ICS) [PDF]

, 2014
Lefki Giannopoulou, Polytimi Panaghiotopoulou‐Gartagani, Eleni Magdalini Kyritsi, Athanasios G. Kaditis, Maria Theodoridou, Vasiliki Spoulou   +5 more
openalex   +1 more source

A Cost-Effectiveness Analysis of the Switch to 20-Valent Pneumococcal Conjugate Vaccine from Lower-Valent Pneumococcal Conjugate Vaccines in the French Pediatric Population. [PDF]

Infect Dis Ther
Fiévez S, Ta A, Bellier L, Blanc E, El Khoury JY, Beillat M, Sabra A, Sivignon M, Ilic A, Perdrizet J.   +9 more
europepmc   +1 more source

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand

, 2018
Lijoy Varghese, Louise Talbot, Andrea Govender, Xuhao Zhang, Bruce A. Mungall   +4 more
openalex   +1 more source

Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial. [PDF]

N Engl J Med
Gallagher KE, Lucinde R, Bottomley C, Kaniu M, Suaad B, Mutahi M, Mwalekwa L, Ragab S, Twi-Yeboah L, Berkley JA, Hamaluba M, Karani A, Shangala J, Otiende M, Gardiner E, Mugo D, Smith PG, Tabu C, Were F, Goldblatt D, Scott JAG.   +20 more
europepmc   +1 more source

Neutrophils induce effective antibody responses to the pneumococcal conjugate vaccine by inhibiting regulatory T cells [PDF]

Essi Y. I. Tchalla, Anagha Betadpur, Andrew Y. Khalil, Elena López‐Camacho, Manmeet Bhalla, Ming Xian Chang, Elizabeth A. Wohlfert, Elsa N. Bou Ghanem   +7 more
openalex   +1 more source

A Narrative Review of Pneumococcal Conjugate Vaccine Choices for Greater Access and Protection against Pneumococcal Diseases in the Philippines. [PDF]

Acta Med Philipp
Lota MMM, Capeding RZ, Garcia FB, Medina JRC, Serrano JA, Lumangaya CR, Belizario VY.   +6 more
europepmc   +1 more source

Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco [PDF]

, 2017
Idrissa Diawara, Abouddihaj Barguigua, Khalid Katfy, Kaotar Nayme, Houria Belabbès, Mohammed Timinouni, Khalid Zerouali, Naima Elmdaghri   +7 more
openalex   +1 more source

Cost effectiveness of a 21-valent pneumococcal conjugate vaccine in adults: A systematic review of economic evaluations. [PDF]

Can Commun Dis Rep
Simmons AE, Ximenes R, Gebretekle GB, Salvadori MI, Wong E, Tuite AR.   +5 more
europepmc   +1 more source

Changing Landscape of Invasive Pneumococcal Disease Serotypes and Antimicrobial Resistance Following Pneumococcal Conjugate Vaccine Introduction in the Middle East and North Africa Region: A Systematic Review. [PDF]

Vaccines (Basel)
El Zein Z, Nasser M, Boutros CF, Tfaily N, Reslan L, Faour K, Merhi S, Damaj S, Moumneh MB, Bou Dargham T, Youssef N, Haj M, Bou Karroum S, Khafaja S, Assaf Casals A, Chamseddine S, Hneiny L, Dbaibo GS.   +17 more
europepmc   +1 more source

Immunogenicity and safety of the 15-valent pneumococcal conjugate vaccine, a systematic review and meta-analysis. [PDF]

NPJ Vaccines
Wagner G, Gartlehner G, Thaler K, Ledinger D, Feyertag J, Klerings I, Saif-Ur-Rahman KM, Devane D, Olsson K, Adel Ali K, Vygen-Bonnet S, Salo H, Zavadska D, Grgič Vitek M, Oona M, Cunney R, Tuerlinckx D, Kristensen Lomholt F, Sommer I.   +18 more
europepmc   +1 more source